- Country: Ecuador
- Summary: Acquisition of the Adalimumab Medication Parenteral Liquid 40Mg Pac 2025, Act of Pharmacotherapy Committee Gg-Cft-2025-001
- ECT Ref No: 126231011
- Deadline: 20 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: USD 562959.36
- Notice Type: Tender
- Document Ref. No.: SIE-HTMC-2025-058
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Process purpose: Acquisition of the Adalimumab Medication Parenteral Liquid 40mg PAC 2025, Act of Pharmacotherapy Committee GG-CFT-2025-001
: Good
Description: Acquisition of the Adalimumab Medication Parenteral Liquid 40mg PAC 2025, Act of Pharmacotherapy Committee GG-CFT-2025-0
Hiring: Electronic Inverse Auction -
Payment against goods delivery works or service 100.00%
Offers Technical. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAcquisition of the Adalimumab Medication Parenteral Liquid 40Mg Pac 2025, Act of Pharmacotherapy Committee Gg-Cft-2025-001 - Ecuador Tender
The SPECIALTIES HOSPITAL - TEODORO MALDONADO CARBO, a Government sector organization in Ecuador, has announced a new tender for Acquisition of the Adalimumab Medication Parenteral Liquid 40Mg Pac 2025, Act of Pharmacotherapy Committee Gg-Cft-2025-001. This tender is published on EcuadorTenders under ECT Ref No: 126231011 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-20.
The estimated tender value is USD 562959.36, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
